Our Strategy for the Treatment of Venous Malformations

DOI Web Site 34 References
  • Nomura Tadashi
    Division of Plastic Surgery, National Hospital Organization Himeji Medical Center
  • Sakurai Atsushi
    Division of Plastic Surgery, Nippon Steel Hirohata Hospital
  • Nagata Ikuko
    Department of Plastic Surgery, Kobe University Graduate School of Medicine
  • Terashi Hiroto
    Department of Plastic Surgery, Kobe University Graduate School of Medicine
  • Tahara Shinya
    Department of Plastic Surgery, Kobe University Graduate School of Medicine

Bibliographic Information

Other Title
  • 血行動態を考慮した静脈奇形に対するわれわれの治療戦略―硬化療法の適応と限界について―

Search this article

Abstract

<p>Sixty-two patients with venous malformations underwent percutanous sclerotherapy with direct puncture and injection of 5% ethanolamine oleate or 1% polidocanol. The late results were excellent or good in 51 patients (82.3%), fair in 8, poor in 3. Of three poor cases, two cases were Klippel-Trenaunay syndrome. Complications of the treatment included soft tissue necrosis (16 sessions: 14.7%), hemoglobinuria (45 sessions: 41.3%). All cases with soft tissue necrosis were resolved conservatively. The healing time of skin necrosis (mean 58.6 days) was significantly longer than that of mucosal necrosis (mean 26.1 days). In conclusion, sclerotherapy with ethanolamine oleate or polidocanol is a safe and effective treatment for many cases with venous malformations. However, at this time, it is diffi cult to treat the lesions of the orbit or large malformations with Klippel-Trenaunay syndrome with safety and effect.</p>

Journal

References(34)*help

See more

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top